News | i2.JP (Innovation Infusion Japan) | Astrazeneca

News

• Event2026.5.186/2＆6/9 Practical Seminar Program for Pre-IND Strategy—Design Your Approach with Experts in U.S. and Japanese Regulatory and Development Strategies
• Partner2026.5.18KPUM Cardiac Arrhythmia Research and Innovation, Lundoch Diagnostics, ProductLife Japan K.K., and SVAR LIFE SCIENCE joined i2.JP
• Partner2026.4.27HORIBA, Ltd., Richmond Pharmacology, and NIJI.RIBBON joined i2.JP
• Partner2026.4.20Eisai Co., Ltd, Light Touch Technology Inc., and yuruttokaigo Inc. joined i2.JP
• Collaborations2026.4.13The Challenge: “Medication Adherence in Nogata City, Fukuoka Prefecture”, Exploring the Root Causes and Seeking Solutions!
• Event2026.4.13From Osaka to the world! Collaborative Overseas Expansion Support Project: 'Healthcare Companies Pioneering the World' (Deadline: 5/1).
• Event2026.4.65/12　16 life sciences start-ups take to the stage! Nakanoshima Qross Innovation Challenge
• Event2026.4.64/8 Kobe Univ. × Nakanoshima Qross: 'Strategies for the social implementation of medical technology innovation through interdisciplinary collaboration at Kobe Univ'.
• Partner2026.3.30ELAN Corporation and NANO Holdings, Inc. joined i2.JP
• Partner2026.3.23Plug and Play Japan, KINS Co., Ltd., and Antibody Therapeutics, Inc. joined i2.JP
• Partner2026.3.9ShareMedical Inc. and thymia joined i2.JP
• Event2026.3.23/12 NQ Global Startup Gateway "R7 Achievement Showcase"
• Challenge Application2026.2.24New Challenge Application: Call for Collaborators to Unlock the Potential of Children Who Refuse to Attend School
• Partner2026.2.16Junior Chamber International Osaka and VOCs DeepTech Lab Inc joined i2.JP
• Event2026.2.92/24 “Boehringer Ingelheim Partnering Day ( Piblic Session)”
• Partner2026.2.9arkray,inc., Health Science Evaluation Academy Co., Ltd., and Seven Point One joined i2.JP
• Event2026.2.22/18 “Hokkaido Supporters Gathering Meetup! - Accelerating Research in the Northern Frontier: The Form of ‘University Collaboration, Hubs, and Support’”
• Partner2026.1.26i3-Medical Inc., APOSTRO Co., Ltd., and SANTAM.Inc joined i2.JP